临床实践建议:蛇咬伤相关急性肾损伤
该文由印度专家小组基于PubMed文献、印度政府标准治疗指南、WHO指南和KDIGO急性肾损伤指南制定蛇咬伤相关急性肾损伤(SAKI)的临床实践建议。核心推荐包括早期识别中毒综合征、及时给予多价抗蛇毒血清、对凝血和肾脏参数进行方案化监测、按KDIGO指征标准化使用肾脏替代治疗,并支持管理蛇毒诱导消耗性凝血病、横纹肌溶解和血栓性微血管病。建议还针对儿童、孕妇、既往肾病患者及非「四大类」蛇咬伤者给出特殊考虑。作者结论认为SAKI通过及时干预可预防可治疗,但存活者仍有慢性肾病风险,旨在统一印度多学科诊疗以降低死亡率和改善肾脏结局。
要点
- 早期识别蛇咬伤中毒综合征并及时给予多价抗蛇毒血清是SAKI管理的核心推荐。
- 对蛇咬伤患者应方案化监测凝血和肾脏参数,并按KDIGO指征标准化使用肾脏替代治疗。
- 需支持性管理蛇毒诱导消耗性凝血病、横纹肌溶解和血栓性微血管病。
- 儿童、孕妇、既往肾病患者及非「四大类」蛇咬伤者需特殊考虑。
- SAKI存活者仍面临慢性肾病风险,作者强调跨学科标准化诊疗以改善肾脏结局。
适用人群与场景
- 蛇咬伤中毒患者,尤其是蝰蛇科和部分眼镜蛇科蛇咬伤者,涵盖儿童、孕妇、既往肾病患者及非「四大类」蛇咬伤者。
处置流程与药物剂量
- 早期识别蛇咬伤中毒综合征并 promptly 给予多价抗蛇毒血清。
- 对凝血和肾脏参数进行方案化监测。
- 按KDIGO指征标准化使用肾脏替代治疗(KRT)。
- 对蛇毒诱导消耗性凝血病(VICC)、横纹肌溶解和血栓性微血管病(TMA)进行支持性管理。
研究设计与关键结果
- 本文为专家小组基于PubMed文献、印度政府标准治疗指南(STG)、世界卫生组织(WHO)指南和KDIGO急性肾损伤指南制定的临床实践建议,推荐经专家小组讨论形成。
证据类型、等级与局限
- 证据类型:专家共识/临床实践建议;基于文献回顾(PubMed)、印度政府标准治疗指南、WHO指南和KDIGO指南,经专家小组讨论形成推荐。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者建议早期识别蛇咬伤中毒综合征并及时给予多价抗蛇毒血清,以降低SAKI风险。
- 作者建议对蛇咬伤患者方案化监测凝血和肾脏参数,并按KDIGO指征使用肾脏替代治疗。
- 作者建议对VICC、横纹肌溶解和TMA进行支持性管理。
- 作者建议对儿童、孕妇、既往肾病患者及非「四大类」蛇咬伤者给予特殊考虑。
- 作者认为SAKI存活者需关注慢性肾病风险,建议统一印度全科医学、肾脏病学和重症医学科团队的诊疗路径。
指南或共识出处
- 印度政府标准治疗指南(STG)
- 世界卫生组织(WHO)指南
- 肾脏病改善全球结局(KDIGO)急性肾损伤指南
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Snakebite is a neglected tropical disease of major public health importance in India, contributing to significant morbidity and mortality. Acute kidney injury (AKI) is among the most serious complications of envenomation, particularly with viperid and some elapid species, and is associated with long-term chronic kidney disease (CKD) risk.
OBJECTIVE: This article aims to provide evidence-based recommendations for the recognition, evaluation, and management of snakebite-envenomation-associated AKI (SAKI), integrating global best practices with national treatment protocols and resource realities.
MATERIALS AND METHODS: The authors reviewed available literature through PubMed and international recommendations, including the Government of India's Standard Treatment Guidelines (STG), World Health Organization (WHO) guidance, and Kidney Disease Improving Global Outcomes (KDIGO) AKI guidelines. As per the available evidence, the recommendations were formulated through expert panel deliberations.
RESULTS: Key recommendations include early recognition of envenomation syndromes, prompt administration of polyvalent antisnake venom (ASV), protocolized monitoring of coagulation and renal parameters, and standardized use of kidney replacement therapy (KRT) according to KDIGO indications. Supportive management of venom-induced consumption coagulopathy (VICC), rhabdomyolysis, and thrombotic microangiopathy (TMA) is emphasized. Special considerations have been outlined for children, pregnant women, patients with preexisting kidney disease, and those bitten by non-"Big Four" snakes.
CONCLUSION: SAKI is preventable and treatable with timely intervention, but survivors remain at risk of CKD. With these recommendations, the authors have tried to standardize the diagnostic and therapeutic approach across general medicine, nephrology, and critical care medicine teams in India, aiming to reduce mortality and improve renal outcomes.
参考来源
- Sharma S, Sahoo TK, Kollengode R, et al. Clinical Practice Recommendations: Snakebite-envenomation-associated Acute Kidney Injury. J Assoc Physicians India. 2026. PMID: 42543937. doi:10.59556/japi.74.1528
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。